{
  "id": 10675943,
  "title": "Indo Borax Completes Acquisition Of 64.26% Stake In Kronox Lab Sciences",
  "url": "https://urgent.news/2026/09/29/indo-borax-completes-acquisition-of-64-26-stake-in-kronox-lab-sciences",
  "topic": "world",
  "section": "World",
  "published": "2026-09-29T10:21:24.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/indo-borax-completes-acquisition-of-6426-stake-in-kronox-lab-sciences"
  },
  "original_language": "en",
  "account": "Indo Borax & Chemicals Ltd has finalized the acquisition of a 64.26% stake in Kronox Lab Sciences Ltd, according to a recent announcement. The purchase of 2,38,44,000 equity shares was completed on September 29, 2026. Indo Borax entered into a share purchase agreement on August 20, 2026, with the sellers being Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani, and Jogindersingh Gianchand Jaswal. The acquired shares represent a majority stake in Kronox Lab Sciences Ltd, making Indo Borax the majority shareholder in the company. Sunil Malhotra, Director at Indo Borax & Chemicals Ltd, signed the disclosure to confirm the acquisition, which has been requested to be recorded by the stock exchanges. This story is based on company exchange filings and is intended for informational purposes only. Investors are advised to carefully assess the risks before making any investment decisions.",
  "summary": "Mumbai: Indo Borax & Chemicals Ltd has completed the acquisition of a 64.26 per cent stake in Kronox Lab Sciences Ltd . The company announced on Friday that the acquisition of 2,38,44,000 equity shares was finalised on September 29, 2026. Acquisition Details Indo Borax, acting as the purchaser, had previously entered into a share purchase agreement (SPA) on August 20, 2026. The sellers in the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}